Why Blackstone investors backed its $14.6bn life science recap

The massive transaction might have raised eyebrows for other firms, but as one consultant said 'that's just Blackstone being Blackstone.'

PRIVATE REAL ESTATE

Register to unlock this content

• Daily global private real estate news and market intelligence
• Expertly curated insights to keep you ahead of the market
• Faster, data-driven decision-making powered by our AI interface, Ask PEI
• Access to proprietary research and reports
• Selected investor strategy and competitor performance data

Register nowFind out more

InvestorsManagersNorth America